Jean-Luc Pagani

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


49 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2009 | 2008 | 2007 | 2004 | 2002 | 2001 | 1997 | 1996 | 1995 |
In press
 
Antibacterial and antifungal drug concentrations in intra-abdominal abscesses: a prospective clinical study.
Cancela Costa A., Grass F., Andres Cano I., Desgranges F., Delabays C., Kritikos A., Glampedakis E., Buclin T., Duran R., Guery B. et al. Antimicrobial agents and chemotherapy. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F0170FF7132]
2024
 
Role of source control in critically ill candidemic patients: a multicenter retrospective study.
Marangos M., Ioannou P., Senn L., Spiliopoulou A., Tzalis S., Kolonitsiou F., Valta M., Kokkini S., Pagani J.L., Stafylaki D. et al., 2024/10. Infection, 52 (5) pp. 1733-1743. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E12FF5C85FA]
Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS).
Couchepin J., Reinhold I., Kronig I., Guidi M., Buclin T., Schreiber P.W., Neofytos D., Lamoth F., Fungal Infection Network of Switzerland (FUNGINOS), 2024/05. Open forum infectious diseases, 11 (5) pp. ofae223. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7689B1E13106]
Serial monitoring of pancreatic stone protein for the detection of sepsis in intensive care unit patients with complicated abdominal surgery: A prospective, longitudinal cohort study.
Filippidis P., Hovius L., Tissot F., Orasch C., Flückiger U., Siegemund M., Pagani J.L., Eggimann P., Marchetti O., Lamoth F. et al., 2024/03/11. Journal of critical care, 82 p. 154772. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BB2800A65195]
2023
 
Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
Galperine T., Choi Y., Pagani J.L., Kritikos A., Papadimitriou-Olivgeris M., Méan M., Scherz V., Opota O., Greub G., Guery B. et al., 2023/08/18. BMC infectious diseases, 23 (1) p. 537. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4AC9A4A0DF4]
The effect of duration of antimicrobial treatment for bacteremia in critically ill patients on in-hospital mortality - Retrospective double center analysis.
Zuercher P., Moser A., Frey M.C., Pagani J.L., Buetti N., Eggimann P., Daneman N., Fowler R., Que Y.A., Prazak J., 2023/04. Journal of critical care, 74 p. 154257. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8749F3ABAD84]
 
Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
Kritikos A., Caruana G., Poissy J., Mamin A., Bachmann D., Pagani J.L., Coste A.T., Lamoth F., 2023/02/22. Journal of clinical microbiology, 61 (2) pp. e0169122. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_24963B96DCC0]
Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patients.
Waldeck F., Boroli F., Zingg S., Walti L.N., Wendel-Garcia P.D., Conen A., Pagani J.L., Boggian K., Schnorf M., Siegemund M. et al., 2023/01. Influenza and other respiratory viruses, 17 (1) pp. e13059. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1307E3078EDF]
2022
 
Corrigendum to "Validation and clinical application of a multiplex high performance liquid chromatography - Tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections" [J. Chromatogr. B 1157 (2020) 122160].
Decosterd L.A., Mercier T., Ternon B., Cruchon S., Guignard N., Lahrichi S., Pesse B., Rochat B., Burger R., Lamoth F. et al., 2022/11/15..
[DOI][WoS][Pmid][serval:BIB_D81DA54DDABE]
Mutation to ispA Produces Stable Small-Colony Variants of Pseudomonas aeruginosa That Have Enhanced Aminoglycoside Resistance.
Pitton M., Oberhaensli S., Appiah F., Pagani J.L., Fournier A., Jakob S.M., Que Y.A., Cameron D.R., 2022/07/19. Antimicrobial agents and chemotherapy, 66 (7) pp. e0062122. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62D262061251]
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.
Kritikos A., Gabellon S., Pagani J.L., Monti M., Bochud P.Y., Manuel O., Coste A., Greub G., Perreau M., Pantaleo G. et al., 2022/05/18. Viruses, 14 (5) p. 1089. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7AA364497D07]
 
Comparison of temporal evolution of computed tomography imaging features in COVID-19 and influenza infections in a multicenter cohort study.
Fischer T., El Baz Y., Scanferla G., Graf N., Waldeck F., Kleger G.R., Frauenfelder T., Bremerich J., Schmidt Kobbe S., Pagani J.L. et al., 2022. European journal of radiology open, 9 p. 100431. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_76BC8C80F713]
2021
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital.
Battistolo J., Glampedakis E., Damonti L., Poissy J., Grandbastien B., Kalbermatter L., Pagani J.L., Eggimann P., Bochud P.Y., Calandra T. et al., 2021/12. Mycoses, 64 (12) pp. 1512-1520. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_59B304F1CB77]
Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study.
Pugin J., Daix T., Pagani J.L., Morri D., Giacomucci A., Dequin P.F., Guitton C., Que Y.A., Zani G., Brealey D. et al., 2021/04/20. Critical care, 25 (1) p. 151. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E46CA007B5DF]
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
Bibert S., Guex N., Lourenco J., Brahier T., Papadimitriou-Olivgeris M., Damonti L., Manuel O., Liechti R., Götz L., Tschopp J. et al., 2021. Frontiers in immunology, 12 p. 666163. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_91CEC9119F7E]
2020
 
Chlorhexidine-dress related contact dermatitis-the precautionary principle is no more relevant!
Eggimann P., Pagani J.L., Revelly J.P., Que Y.A., 2020/12/09. Critical care, 24 (1) p. 687. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4252A18BDB62]
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients.
Lamoth F., Glampedakis E., Boillat-Blanco N., Oddo M., Pagani J.L., 2020/12. Clinical microbiology and infection, 26 (12) pp. 1706-1708. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8331B09AD13F]
Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
Decosterd L.A., Mercier T., Ternon B., Cruchon S., Guignard N., Lahrichi S., Pesse B., Rochat B., Burger R., Lamoth F. et al., 2020/11/10. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1157 p. 122160. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2ABB9B287690]
SPHN/PHRT: Forming a Swiss-Wide Infrastructure for Data-Driven Sepsis Research.
Egli A., Battegay M., Büchler A.C., Bühlmann P., Calandra T., Eckert P., Furrer H., Greub G., Jakob S.M., Kaiser L. et al., 2020/06/16. pp. 1163-1167 dans Digital Personalized Health and Medicine, IOS Press.
[URN][DOI][WoS][Pmid][serval:BIB_DBFE87C40559]
 
Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis
Kritikos Antonios, Poissy Julien, Croxatto Antony, Bochud Pierre-Yves, Pagani Jean-Luc, Lamoth Frederic, 2020/04/01. Journal of Clinical Microbiology, 58 (6) pp. e01996-19. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4BEDA4FB01DB]
Risk factors for candidemia: a prospective matched case-control study.
Poissy J., Damonti L., Bignon A., Khanna N., Von Kietzell M., Boggian K., Neofytos D., Vuotto F., Coiteux V., Artru F. et al., 2020/03/18. Critical care, 24 (1) p. 109. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A42B1C805146]
 
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study.
Regina J., Papadimitriou-Olivgeris M., Burger R., Le Pogam M.A., Niemi T., Filippidis P., Tschopp J., Desgranges F., Viala B., Kampouri E. et al., 2020. PloS one, 15 (11) pp. e0240781. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE26AADAD401]
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University Hospital.
Kampouri E., Filippidis P., Viala B., Méan M., Pantet O., Desgranges F., Tschopp J., Regina J., Karachalias E., Bianchi C. et al., 2020. BioMed research international, 2020 p. 9126148. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_458CAB0E5E15]
2019
 
Isavuconazole brain penetration in cerebral aspergillosis.
Lamoth F., Mercier T., André P., Pagani J.L., Pantet O., Maduri R., Guery B., Decosterd L.A., 2019/06/01. The Journal of antimicrobial chemotherapy, 74 (6) pp. 1751-1753. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DBC07C267A48]
Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years.
Eggimann P., Pagani J.L., Dupuis-Lozeron E., Ms B.E., Thévenin M.J., Joseph C., Revelly J.P., Que Y.A., 2019/06. Intensive care medicine, 45 (6) pp. 823-833. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DF96B4DC9E06]
L'if, un conifère ornemental parfois fatal
Bonjour Thierry, Varlet Vincent, Augsburger Marc, Pagani Jean-Luc, Pantet Olivier, 2019/04/24. Forum Médical Suisse ‒ Swiss Medical Forum, 19 (17-18) pp. 303-305. Peer-reviewed.
[URN][DOI][serval:BIB_371276E85ADE]
2018
 
Reply to Sorooshian and Snow, "Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?"
Fournier A., Eggimann P., Pantet O., Pagani J.L., Dupuis-Lozeron E., Pannatier A., Sadeghipour F., Voirol P., Que Y.A., 2018/10. Antimicrobial agents and chemotherapy, 62 (10). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6277E33537AC]
 
Arrêt cardiaque suite à l’administration accidentelle d’amphotéricine B sous forme désoxycholate
Cuda Loredana, Mury Caroline, Pagani Jean-Luc, Revelly Jean-Pierre, Livio Françoise, Aubert John-David, Schaller Marie-Denise, Voirol Pierre, Eggimann Philippe, Que Yok-Ai, 2018. Forum Medical Suisse, 18 (50) pp. 1067-1071. Peer-reviewed.
[serval:BIB_2D46003F1D03]
2017
 
Staphylococcus aureus carriage at admission predicts early-onset pneumonia after burn trauma.
Fournier A., Voirol P., Krähenbühl M., Bonnemain C.L., Fournier C., Dupuis-Lozeron E., Pantet O., Pagani J.L., Revelly J.P., Sadeghipour F. et al., 2017/04. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 36 (3) pp. 523-528. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3570AFA2FB29]
2016
 
Antibiotic consumption to detect epidemics of Pseudomonas aeruginosa in a burn centre: A paradigm shift in the epidemiological surveillance of Pseudomonas aeruginosa nosocomial infections.
Fournier A., Voirol P., Krähenbühl M., Bonnemain C.L., Fournier C., Pantet O., Pagani J.L., Revelly J.P., Dupuis-Lozeron E., Sadeghipour F. et al., 2016/05. Burns : journal of the International Society for Burn Injuries, 42 (3) pp. 564-570. Peer-reviewed.
[DOI][Pmid][serval:BIB_3BB207157576]
2015
 
Effective Treatment of Invasive Aspergillus fumigatus Infection Using Combinations of Topical and Systemic Antifungals in a Severely Burned Patient.
Fournier A., Pantet O., Guerid S., Eggimann P., Pagani J.L., Revelly J.P., Hauser P.M., Marchetti O., Fontanella S., Letovanec I. et al., 2015. Journal of Burn Care and Research, 36 (2) pp. e85-e89. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7801E93C98E1]
 
Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
Fournier A., Eggimann P., Pagani J.L., Revelly J.P., Decosterd L.A., Marchetti O., Pannatier A., Voirol P., Que Y.A., 2015. Burns, 41 (5) pp. 956-968. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_250BAF754387]
Low C-reactive protein values at admission predict mortality in patients with severe community-acquired pneumonia caused by Streptococcus pneumoniae that require intensive care management.
Que Y.A., Virgini V., Lozeron E.D., Paratte G., Prod'hom G., Revelly J.P., Pagani J.L., Charbonney E., Eggimann P., 2015. Infection, 43 (2) pp. 193-199. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_237BD48AFB69]
 
Preventing invasive candida infections. Where could we do better?
Eggimann P., Que Y.A., Revelly J.P., Pagani J.L., 2015. Journal of Hospital Infection, 89 (4) pp. 302-308. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_134619C45F58]
 
Prognostication of Mortality in Critically Ill Patients With Severe Infections.
Que Y.A., Guessous I., Dupuis-Lozeron E., Alves de Oliveira C.R., Ferreira Oliveir C., Graf R., Seematter G., Revelly J.P., Pagani J.L., Liaudet L. et al., 2015. Chest, 148 (3) pp. 674-682. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_37270C5628E4]
2014
Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.
Que Y.A., Lazar H., Wolff M., François B., Laterre P.F., Mercier E., Garbino J., Pagani J.L., Revelly J.P., Mus E. et al., 2014. European Journal of Clinical Microbiology and Infectious Diseases, 33 (10) pp. 1861-1867. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EDD8EE678A5D]
2013
Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.
Niven D.J., Laupland K.B., Tabah A., Vesin A., Rello J., Koulenti D., Dimopoulos G., de Waele J., Timsit J.F., EUROBACT Investigators, 2013/12/10. Critical care (London, England), 17 (6) pp. R289.
[URN][DOI][Pmid][serval:BIB_FBF5F4D4E761]
2011
 
Burnout in ICU caregivers: a multicenter study of factors associated to centers.
Merlani P., Verdon M., Businger A., Domenighetti G., Pargger H., Ricou B., STRESI+ Group, 2011/11/15. American journal of respiratory and critical care medicine, 184 (10) pp. 1140-1146. Peer-reviewed.
[DOI][Pmid][serval:BIB_3E7FACD76449]
2009
Thymoma, immunodeficiency, and herpes simplex virus infections.
Méan M., Schaller M.D., Asner S., Meylan P., Pagani J.L., Tarr P., Eggimann P., 2009. Médecine et Maladies Infectieuses, 39 (5) pp. 344-347. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_02437680064E]
2008
Management of catheter-related infection.
Pagani J.L., Eggimann P., 2008/02. Expert Review of Anti-infective Therapy, 6 (1) pp. 31-37.
[URN][DOI][WoS][Pmid][serval:BIB_881422582A3C]
2007
 
Infections liées aux cathéters en réanimation: Recommandations pour la pratique clinique. [Management of catheter-related infection: recommendations for clinical practice]
Pagani JL Eggimann P, 2007/12. Revue Médicale Suisse, 3 (137) pp. 2836-9.
[Pmid][serval:BIB_AE17FDC23E14]
2004
 
Asthme aigu sévère [Severe acute asthma]
Pagani J.L., Oddo M., Schaller M.D., 2004. Revue Médicale de la Suisse romande, 124 (6) pp. 333-336.
[Pmid][serval:BIB_237A5F52E8B5]
2002
Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial.
Pagani J.L., Chave J.P., Csajka C., Glauser M.P., Bille J., 2002/08. The Journal of antimicrobial chemotherapy, 50 (2) pp. 231-240. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_63978C9C55C1]
2001
Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients.
Csajka C., Décosterd L.A., Buclin T., Pagani J.L., Fattinger K., Bille J., Biollaz J., 2001/12. European journal of clinical pharmacology, 57 (10) pp. 723-727. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0E4686924252]
1997
Monitoring responses to antiretroviral treatment in human immunodeficiency virus type 1 (HIV-1)-infected patients by serial lymph node aspiration
Burgisser P., Spertini F., Weyrich-Suter C., Pagani J. L., Meylan P. R., 1997/05. Journal of Infectious Diseases, 175 (5) pp. 1202-5.
[URN][DOI][WoS][Pmid][serval:BIB_5016E377940E]
1996
 
Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.
Boerlin P., Boerlin-Petzold F., Goudet J., Durussel C., Pagani J.L., Chave J.P., Bille J., 1996. Journal of Clinical Microbiology, 34 (5) pp. 1235-1248.
[WoS][Pmid][serval:BIB_8E6C153AA237]
1995
 
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
Sanglard D., Kuchler K., Ischer F., Pagani J. L., Monod M., Bille J., 1995/11. Antimicrobial Agents and Chemotherapy, 39 (11) pp. 2378-86.
[WoS][Pmid][serval:BIB_77E8ECAB786E]
 
Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users
Boerlin P., Boerlin-Petzold F., Durussel C., Addo M., Pagani J. L., Chave J. P., Bille J., 1995/05. Journal of Clinical Microbiology, 33 (5) pp. 1129-35. Peer-reviewed.
[WoS][Pmid][serval:BIB_870B904144C9]
 
Transmission of oral Candida albicans strains between HIV-positive patients
Boerlin P., Addo M., Boerlin-Petzold F., Durussel C., Pagani J. L., Chave J. P., Bille J., 1995/04. Lancet, 345 (8956) pp. 1052-3. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4B4F8201AF1B]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University